Defining response to anti-VEGF therapies in neovascular AMD - Amoaku, W M; Chakravarthy, U; Gale, R; Gavin, M; Ghanchi, F; Gibson, J; Harding, S; Johnston, R L; Kelly, S; Lotery, A; Mahmood, S; Menon, G; et al. (Eye (London), 2015)
Keywords: 692/1807; Angiogenesis Inhibitors - therapeutic use; Humans; Intravitreal Injections; Laboratory Medicine; Medicine; Medicine & Public Health; Ophthalmology; Pharmaceutical Sciences/Technology; Practice Guidelines as Topic; Review; Surgery; Surgical Oncology; Treatment Outcome; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity - physiology; Wet Macular Degeneration - drug therapy; Wet Macular Degeneration - physiopathology